Molecular Targeting Technologies, Inc.

West Chester, PA Doing business as Mtti Molecular Targeting Technologies, Inc.

UEI
Y2FNW7N1V267
CAGE
489G0
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
833 Lincoln Ave #9, West Chester, PA 19380, USA
Website
mtarget.com
Founded
2011
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Quick answers

What is Molecular Targeting Technologies, Inc.'s UEI?

Molecular Targeting Technologies, Inc.'s Unique Entity ID (UEI) in SAM.gov is Y2FNW7N1V267.

What is Molecular Targeting Technologies, Inc.'s CAGE code?

Molecular Targeting Technologies, Inc.'s CAGE code is 489G0.

What is Molecular Targeting Technologies, Inc.'s primary NAICS code?

Molecular Targeting Technologies, Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).

Where is Molecular Targeting Technologies, Inc. located?

Molecular Targeting Technologies, Inc.'s physical address in SAM.gov is 833 Lincoln Ave #9, West Chester, PA 19380, USA.

Is Molecular Targeting Technologies, Inc. registered in SAM.gov?

Yes. Molecular Targeting Technologies, Inc.'s SAM.gov registration is active through March 2, 2027.

What is Molecular Targeting Technologies, Inc.'s most recent federal award?

Molecular Targeting Technologies, Inc.'s most recent federal grant award is Targeted radionuclide therapy for non-small cell lung cancer with LU-177 ebrgd - project summary/abstract: lung cancer… (R01CA299133), from National Cancer Institute, on August 24, 2026.

On GovTribe

See Molecular Targeting Technologies, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors